###### Strengths and limitations of this study

-   A double-blind, randomised, sham-controlled, cross-over pilot trial.

-   Employed polysomnography, the gold-standard test for investigating sleep physiology and pathophysiology.

-   The first to investigate positional therapy during sleep in pregnancy.

-   Performed in a controlled sleep laboratory setting over two nights; therefore, caution should be taken when extrapolating the results to the home setting and across the third trimester.

-   Due to the small sample, it may have been underpowered.

Introduction {#s1}
============

Background {#s1a}
----------

Stillbirth (SB) and low birth weight (LBW) are devastating complications of pregnancy. Recently, five studies have demonstrated an association between maternal supine sleep position in late pregnancy and the risk of late term SB[@R1] and LBW.[@R1] The population attributable risk of supine sleep for SB has been reported as being between 3.7% and 37%,[@R1] suggesting that a significant proportion of late term SB could be averted if supine sleep was avoided. A number of major risk factors for SB and LBW are not modifiable in the course of the pregnancy (eg, elevated body mass index (BMI), advanced maternal age); however, maternal supine sleep is potentially modifiable with the majority of third-trimester pregnant women spending up to 25% of their sleep time supine.[@R6]

The contribution of supine sleep to LBW and SB is biologically plausible due to inferior vena cava compression by the gravid uterus, affecting maternal haemodynamics[@R9] and fetal oxygenation.[@R14] The supine position also exacerbates sleep-disordered breathing (SDB),[@R26] which has been linked to adverse pregnancy outcomes.[@R28] In persons with mild to moderate SDB, the majority experience most of their breathing abnormalities while sleeping supine.[@R31] Positional therapy (PT) is a simple, safe and effective treatment that helps individuals with SDB maintain a lateral position while sleeping, thus significantly reducing or eliminating their breathing abnormalities.[@R31] Drawing on the concept of PT for SDB, the authors (AJK, AB and KC) designed a PT device for pregnant women called 'PrenaBelt' to minimise supine sleep ([figure 1](#F1){ref-type="fig"}). This study is a randomised pilot trial because it trialled a new intervention on a smaller scale (pilot) to evaluate it for use in a full-scale randomised controlled trial.[@R33]

![Photos of the PrenaBelt (left side, back and front view) and a schematic showing the PrenaBelt laid flat (front and back view).](bmjopen-2017-020256f01){#F1}

Objectives {#s1b}
----------

The primary objective was to evaluate whether the percentage of time spent supine during sleep in the third trimester of pregnancy could be reduced using the PrenaBelt when compared with a sham. Secondary objectives were to evaluate the effect of the PrenaBelt on maternal sleep architecture and respiration in comparison with a sham, evaluate the accuracy of maternal self-reported sleep position and collect feedback from the participants regarding the PrenaBelt.

Methods {#s2}
=======

Randomised pilot trial design {#s2a}
-----------------------------

A single-centre, double-blind, randomised (one-to-one), sham-controlled, cross-over trial. No methodological changes were made after trial commencement.

Patient and public involvement {#s2b}
------------------------------

Patients and the public were not involved in the development of the research question or outcome measures, design of the study, recruitment process, or conduct of the study. During the consent process, participants indicated whether they wished to receive a copy of their personal study results and/or a summary of the overall study results (to be shared by email).

Participants {#s2c}
------------

Participants were recruited by a trained nurse at the IWK Health Centre---a tertiary and primary care centre for women and children with approximately 5000 newborns delivered per year. Overnight polysomnograms (PSGs) were conducted at the Queen Elizabeth II (QEII) Health Sciences Centre Sleep Disorders Clinic. The IWK and QEII are teaching hospitals associated with Dalhousie University in Halifax, Canada. Halifax has a population of approximately 400 000. Participants expressing interest in the study (paper flyer, online advertisement) were screened.

Participants were eligible if they had a low-risk singleton pregnancy and were 18 years of age or older, more than 20 weeks gestation at screening, and residing in the Halifax Regional Municipality. Exclusion criteria included BMI ≥35 kg/m^2^ at the first antenatal appointment for the current pregnancy, pregnancy complicated by obstetric conditions (eg, hypertension, diabetes, intrauterine growth restriction), sleep complicated by any medical conditions (eg, known obstructive sleep apnoea (OSA), insomnia, musculoskeletal deformity affecting sleep position), multiple pregnancy, known fetal abnormality, and non-English speaking and reading.

There was no independent data monitoring committee.

Interventions {#s2d}
-------------

There was no run-in measurement of baseline sleep habits. Each participant underwent two overnight PSG studies between 28 and 37 weeks gestation. The study nights were not required to be consecutive dates, and we did not specify a defined washout period. The only difference between the two nights was the intervention (PrenaBelt or sham) and that participants completed a demographic questionnaire on the first PSG night only. The PrenaBelt is worn at the level of the waist and has four firm plastic balls embedded into foam inserts within the pockets posteriorly ([figure 1](#F1){ref-type="fig"}). The mechanism of action of the PrenaBelt is theoretical and based on the tennis ball technique of PT,[@R34] when supine, the balls apply pressure points across the user's lower back, prompting her to reposition herself in a lateral position to maintain comfort. The sham was identical in appearance, materials and construction to the PrenaBelt, but had soft foam balls instead of firm plastic balls and did not have foam inserts; as such, the sham did not provide pressure points. Participants crossed over to the alternative intervention on the second PSG night.

PSG set-up, including Pro-Tech zRIP Durabelts (Philips Respironics, Murrysville, Pennsylvania, USA) for respiration, PT1 pressure transducers (BRAEBON Medical, Kanata, Canada) for airflow and snoring, electrodes (Natus Medical, Pleasanton, California, USA) for ECG/electroencephalography (EEG)/electrooculography/electromyography and finger-tip pulse oximetry, was by trained research assistants (RAs), in accordance with the American Academy of Sleep Medicine 2014 guidelines,[@R37] and in a private clinical room with continuous monitoring by an RA in a separate room through audio/visual and Embla Sandman Elite sleep diagnostic software.

Immediately before the participant settled to sleep, the unblinded research personnel (co-PI (AJK) or study coordinator (JHW)) entered the room to assist her in donning the assigned intervention (PrenaBelt/sham) without disclosing the identity of the intervention to the participant or the RA in order to maintain blinding. On waking for the day, the participants immediately removed the intervention and placed it in an opaque closed box for collection by the unblinded personnel in order to keep it concealed from the RA. The RA subsequently entered the room and unhooked the PSG equipment. The participant completed a feedback questionnaire and placed it in a sealed envelope for the unblinded personnel. Participants were permitted bathroom breaks and to remove the intervention and/or PSG equipment at any point if they became uncomfortable.

Scoring of PSG's was performed by blinded Registered PSG Technicians, and interpretation was by a blinded sleep medicine physician (DLM).

Outcomes {#s2e}
--------

The prespecified primary outcomes per protocol were the per cent of time spent in the supine and right-lateral positions (we originally intended to minimise both) and the feedback questionnaire; however, for reporting clarity and participant comfort, the PrenaBelt was configured to provide pressure points only when the user was supine, the primary outcome was further specified to be the percentage of time spent supine during sleep only, and the other prespecified primary outcomes were instead reported as secondary outcomes. The primary outcome was documented continuously by an RA via video feed.

Secondary outcomes were total sleep time, sleep time in each position (left lateral, right lateral, supine, prone), percentage of sleep left and right, sleep latency, sleep efficiency, sleep indices (total arousal, spontaneous arousal, periodic limb movement, respiratory arousal, apnoea--hypopnea, respiratory effort-related arousal), percentage of sleep stage (1, 2, 3 and rapid eye movement (REM)), peripheral oxygen saturation (SpO~2~) during sleep, snoring and feedback questionnaire. The questionnaire elicited participants' perceptions of body position at sleep onset and waking, number of changes in position, and estimates of percentage/time spent in each position during sleep. Participants also ranked their satisfaction, comfort level and intention to continue using the PrenaBelt (if it were available) on a 10-point Likert scale (with 10 out of 10 reflecting the highest satisfaction, comfort and intention to use, and 1 out of 10 the lowest).

Per our research protocol and trial registry, supine and non-supine Apnoea--Hypopnea Index (AHI), min/mean/max SpO~2~ while awake and min/mean/max maternal heart rate during wake, REM and non-REM (NREM) states, were also specified as secondary outcomes; however, we were unable to report the supine and non-supine AHI and heart rate data due a software configuration issue nor the awake SpO~2~ values due to data artefact.

Sample size {#s2f}
-----------

This is the first trial investigating PT in pregnant women to reduce supine sleep time. For a one-sided paired t-test with power (β) of 0.80, significance level (α) of 0.05 and detectable effect (d) of −0.5 (difference in mean percentage of time spent sleeping supine by half an SD), which is a medium effect size per the literature regarding Cohen,[@R38] a sample size of 25 (n=25) participants was required. All statistical analyses were conducted using the R Statistical Software package (V.3.2.4 (2016-03-10)).[@R39] There was no planned interim analysis or stopping guidelines.

Randomisation {#s2g}
-------------

Participants were allocated by computer-generated (R), one-to-one, simple randomisation into one of two possible cross-over schemes: PrenaBelt on the first PSG night followed by sham on the second PSG night and vice versa ([figure 2](#F2){ref-type="fig"}). Allocation sequence was concealed via unmarked, security-tinted, sealed envelopes by an independent statistician (MBB). An envelope was drawn in sequence, opened, and the participant's name and birth date were recorded on the enclosed allocation sheet by the unblinded personnel (AJK, JHW) on the participant's first PSG night.

![Enrolment, allocation and analysis of trial participants. PSG, polysomnogram.](bmjopen-2017-020256f02){#F2}

Blinding {#s2h}
--------

Participants, the recruiter and personnel involved in setting up, conducting, scoring and interpreting the PSG were blinded to allocation. The only research personnel unblinded to the allocation were the co-PI (AJK) and the study coordinator (JHW), which was required in order to provide the appropriate intervention to the participant before she went to sleep. It was not feasible to blind the researchers analysing the study data (AJK, JHW, MBB) to the allocation.

Statistical methods {#s2i}
-------------------

Primary and secondary outcomes were compared between interventions by paired t-tests (normal) and Wilcoxon signed-rank tests (non-normal). Cohen's Kappa (κ) was used to assess agreement between categorical variables. Spearman's r and Bland-Altman plots were used for continuous variables.

For continuous variables, normality was assessed using Q-Q plots and Anderson-Darling test. All testing was performed at a 0.05 significance level. Treatment effects (differences in means and OR) and associated CIs were presented at a 95% CI with p values.

Results {#s3}
=======

Between March 2016 and January 2017, 28 participants were assessed for eligibility ([figure 2](#F2){ref-type="fig"}). Following exclusion of three (11%) who declined participation and two (7%) who failed to meet eligibility criteria, 23 were randomised. After randomisation, there were three (13%) drop-outs---all from the PrenaBelt-then-sham group and after completing the first PSG night. Two were due to transportation/childcare reasons, and one was due to an unrelated injury preventing her from sleeping in a horizontal position. Thus, 20 participants---10 from each group---were included in the primary analysis, which was by original assigned groups and on a complete-case basis (drop-outs excluded). The originally planned sample size of 25 participants was not reached due to unforeseen budget restrictions preventing recruitment beyond 20 participants. The length of time between studies for the same participant (washout period) was a median of 1 day (IQR 1--3.25 days; maximum 13 days).

Sample characteristics {#s3a}
----------------------

Baseline demographic, obstetric and sleep habit characteristics of the 20 participants who completed the study are shown in [table 1](#T1){ref-type="table"} per randomised group (n=10 each). The two randomised groups were well balanced with respect to the sample characteristics---there were no statistically significant differences in baseline characteristics between groups (α=0.05). The mean (SD) age was 30.9 (5.0) years. The majority (80%) were Caucasian. The mean (SD) prepregnancy BMI was 26.6 kg/m^2^ (3.3) and rose to a mean of 30.4 kg/m^2^ (3.6) at the time of the first PSG, which took place at a median (IQR) gestational age of 30.0 weeks (28--33.1). Half (50%) of the participants were nulliparous.

###### 

Baseline demographic, obstetric and sleep habit characteristics

                               PrenaBelt-then-sham (n=10)   Sham-then-PrenaBelt (n=10)
  ---------------------------- ---------------------------- ----------------------------
  Age (years)                  31.1 (6.0)                   30.7 (4.1)
  Caucasian ethnicity          6 (60%)                      10 (100%)
  Prepregnancy BMI (kg/m^2^)   27.0 (3.3)                   26.2 (3.5)
  Current BMI (kg/m^2^)        30.9 (3.7)                   29.9 (3.6)
  Gestational age (weeks)      30.9 (3.0)                   30.8 (2.8)
  Gravida                                                   
   1                           4 (40%)                      6 (60%)
   ≥2                          6 (60%)                      4 (40%)
  Sleep duration (hours)       8.0 (7.5--8.0)               7.8 (7.0--8.0)
  In the last week                                          
   Sleep-onset positions                                    
    Left                       7 (70%)                      10 (100%)
    Supine                     3 (30%)                      2 (20%)
    Right                      8 (80%)                      3 (30%)
    Prone                      1 (10%)                      0 (0%)
   Waking positions:                                        
    Left                       8 (80%)                      4 (40%)
    Supine                     4 (40%)                      4 (40%)
    Right                      5 (50%)                      6 (60%)
    Prone                      0 (0%)                       0 (0%)
  When not pregnant                                         
   Sleep-onset positions:                                   
    Left                       2 (20%)                      3 (30%)
    Supine                     3 (30%)                      3 (30%)
    Right                      2 (20%)                      4 (40%)
    Prone                      7 (70%)                      6 (60%)
   Waking positions:                                        
    Left                       5 (50%)                      4 (40%)
    Supine                     4 (40%)                      7 (70%)
    Right                      5 (50%)                      2 (20%)
    Prone                      5 (50%)                      4 (40%)
  Snores ≥3 nights per week    4 (40%)                      3 (30%)
  Sleeps with bed partner      7 (70%)                      10 (100%)
  Pillow use                                                
   Under head                  9 (90%)                      9 (90%)
   Between knees               8 (80%)                      6 (60%)
   Behind back                 3 (30%)                      5 (50%)
   Under tummy                 3 (30%)                      4 (40%)
   Pregnancy pillow            4 (40%)                      1 (10%)

Normally distributed continuous variables are reported as mean (SD). Non-normally distributed continuous variables are presented as median (IQR). Count data are presented as frequency (%).

Percentages for responses to some questions may add to greater than 100% because some participants checked more than one box in response to a question, for example, for sleep-onset position in the last week, some responded 'left' and 'right'.

BMI, body mass index.

The median (IQR) self-reported overnight sleep duration at the time of the first PSG was 8 (7-8) hours. In the week previous to the first PSG (when pregnant), left was the most common position at sleep onset (85%) and waking (60%), although a large proportion of women also reported the supine position at sleep onset and waking (25% and 40%, respectively). When not pregnant, prone was the most common position at sleep onset (65%) and supine was the most common at waking (55%). Most participants used a pillow under their head (90%) and between their knees (70%).

In comparing baseline demographic, obstetric and sleep habit characteristics between the participants who completed the study (n=20) and those who did not (n=3), the groups were similar; however, participants who did not complete the study were younger (mean 26.7 years), had a higher current BMI (mean 32.5 kg/m^2^) and had less self-reported overnight sleep duration (mean 6.8 hours).

Primary outcome {#s3b}
---------------

The primary outcome was not normally distributed. The median (IQR) percentage of sleep time supine on the PrenaBelt night (n=20) and sham night (n=20) was 3.5% (0--16.6) and 16.4% (3.5--25.3), respectively ([table 2](#T2){ref-type="table"}, [figure 3](#F3){ref-type="fig"}). On a one-sided paired Wilcoxon signed-rank test, the median of the pairwise differences (pseudomedian) in percentage of sleep time supine between the sham night versus the PrenaBelt night was significantly greater than 0 (pseudomedian=5.8; 95% CI 0.70 to Inf; p=0.03).

###### 

Primary outcome: percentage (%) of sleep time supine

                 PrenaBelt night (n=20)   Sham night (n=20)   P values
  -------------- ------------------------ ------------------- ----------
  Median (IQR)   3.5 (0--16.6)            16.4 (3.5--25.3)    0.03

![Scatter plot of proportion of sleep time supine (%) versus intervention (PrenaBelt, sham) for each participant. Each line represents one participant.](bmjopen-2017-020256f03){#F3}

Secondary outcomes {#s3c}
------------------

The estimates, 95% CIs and p values for the intervention-associated differences, PrenaBelt versus sham, in the sleep and respiratory variables and user feedback are shown in [table 3](#T3){ref-type="table"}. The median (IQR) number of minutes spent sleeping supine and right lateral was 38.9 (0--72.7) and 90.8 (0--166.1), respectively. The mean (SD) number of minutes spent sleeping left lateral was 180.9 (97.7). The mean (SD) percentage of time spent sleeping in the left-lateral and right-lateral positions was 54.6% (26.7) and 30.3% (27.8), respectively. No time was spent sleeping prone.

Regarding sleep architecture for the complete sample (n=40 nights), the median (IQR) sleep time was 352 min (318--374), sleep efficiency 82% (76--89) and sleep latency 12.8 min (6.7--23.9). The median (IQR) total arousal index was 11.3 (8.4--18.0), spontaneous arousal index 9.8 (7.0--12.0), periodic leg movement arousal index 0 (0--0.8) and respiratory arousal index 0.4 (0--1.0). The mean (SD) percentage of stage 1 sleep was 9.4% (5.6), stage 2 sleep 62.7% (7.9), stage 3 sleep 11.2% (8.3) and REM sleep 16.7% (5.6). For respiratory variables, the median (IQR) AHI was 0.5 (0--1.5), respiratory effort-related arousal index 0 (0--0.2), Respiratory Disturbance Index (RDI) 0.6 (0--1.6), RDI supine 0 (0--0.9), RDI non-supine 0.5 (0--1.6), SpO~2~ maximum and minimum during REM sleep were 98% (98−99) and 92% (90−94), respectively, and SpO~2~ maximum and minimum during NREM sleep were 99% (98--100) and 92% (91--94), respectively. The mean (SD) SpO~2~ during REM and NREM sleep was 96.0 (1.2) and 96.2 (1.0), respectively. Presence of snoring was detected on 26 of 40 (65%) nights. Six participants (30%) indicated that they would make changes to the PrenaBelt---of these, five were with regard to comfort and one was with regard to sizing. There were no statistically significant differences in sleep architecture, respiration or user feedback between the PrenaBelt and sham nights on paired testing (n=20 pairs) ([table 3](#T3){ref-type="table"}).

###### 

Secondary outcomes: time supine, sleep architecture, respiration, user feedback

  -----------------------------------------------------------------------------------------------------------
                                  PrenaBelt\         Sham\               PrenaBelt minus sham\     P values
                                  (n=20)             (n=20)              Difference (95% CI)       
  ------------------------------- ------------------ ------------------- ------------------------- ----------
  Total sleep time (minutes)      353 (318--376)     350 (318--374)      −3.6\* (−33.8 to 21.8)    0.81

  Supine sleep (minutes)          12.3 (0--53.5)     56.8 (12.4--79.1)   −26.4\* (−49.9 to −2.6)   **0.03**

  Left-lateral sleep (minutes)    185.6 (102.5)      176.1 (95.2)        9.5† (−24.3 to 43.3)      0.56

  Right-lateral sleep (minutes)   108.9 (110.1)      101.9 (100.9)       6.9† (−22.9 to 36.7)      0.63

  Percentage sleep left (%)       57.0 (26.9)        52.2 (27.0)         4.8† (−5.1 to 14.8)       0.32

  Percentage sleep right (%)      31.3 (28.8)        29.3 (27.5)         2.0† (−6.0 to 10.1)       0.60

  Sleep latency (minutes)         11.7 (6.7--21.9)   14.5 (7.2--26.2)    2.0\* (−7.2 to 9.4)       0.65

  Sleep efficiency (%)            81 (76--89)        83 (79--88)         −1.4\* (−5.9 to 3.0)      0.46

  Total arousal index             11.2 (8.1--18.0)   12.0 (8.5--15.6)    0.60\* (−1.5 to 3.5)      0.59

  Spontaneous arousal index       10.5 (5.8)         10.3 (5.5)          0.20† (−2.2 to 2.6)       0.86

  PLM arousal index               0 (0--1.0)         0.1 (0--0.7)        0.3\* (−1.5 to 16.0)      0.68

  Respiratory arousal index       0.4 (0--1.1)       0.4 (0--1.0)        0.1\* (−0.5 to 2.1)       0.78

  Percent stage 1 sleep (%)       9.1 (5.2)          9.6 (6.0)           −0.50† (−2.3 to 1.3)      0.56

  Percent stage 2 sleep (%)       64.5 (7.4)         61.0 (8.1)          3.5† (−0.3 to 7.3)        0.07

  Percent stage 3 sleep (%)       10.9 (8.0)         11.5 (8.8)          −0.63† (−2.6 to 1.4)      0.52

  Percent REM sleep (%)           15.5 (6.4)         18 (4.6)            −2.5† (−5.1 to 0.05)      0.05

  Apnoea--Hypopnea Index          0.5 (0--1.5)       0.5 (0--1.5)        −0.14\* (−0.8 to 0.4)     0.51

  RERA index                      0 (0--0.1)         0 (0--0.3)          0.15\* (−0.4 to 4.6)      0.78

  Respiratory Disturbance Index   0.65 (0--1.5)      0.55 (0.15--1.75)   0.2\* (−0.6 to 1.2)       0.67

   RDI while supine               0 (0--0)           0 (0--1.2)          −1.3\* (−11.2 to 2.4)     0.48

   RDI while non-supine           0.2 (0--1.5)       0.5 (0--1.75)       −0.05\* (−0.85 to 1.0)    0.92

  SpO~2~ during REM (%)                                                                            

   Maximum                        98 (98--99)        98.5 (98--99)       0.0\* (−1.0 to 0)         0.28

   Mean                           95.8 (1.2)         96.2 (1.2)          −0.46† (−1.1 to 0.15)     0.13

   Minimum                        92.5 (90.8--94)    92 (89--94)         0.5\* (−1.0 to 2.5)       0.40

  SpO~2~ during NREM (%)                                                                           

   Maximum                        99.0 (98--100)     99 (98--100)        0.5\* (−1.0 to 1.5)       0.46

   Mean                           96.1 (0.88)        96.4 (1.0)          −0.29† (−0.71 to 0.14)    0.17

   Minimum                        92 (91--94)        92.5 (89--94)       0.5\* (−0.5 to 2.5)       0.26

  Presence of snoring             15 (75%)           11 (55%)            2.4‡ (0.54 to 11.9)       0.32

  Satisfaction (out of 10)        7.5 (6.0--8.3)     7.5 (5.5--9.0)      −0.28† (−1.0 to 0.5)      0.46

  Comfort (out of 10)             9.0 (6.8--9.3)     9.0 (7.8--10)       −1\* (−2.8 to 0)          0.06

  Intention to use (out of 10)    8.0 (5.8--8.0)     7.0 (6.0--9.0)      −0.1† (−1.0 to 0.8)       0.81
  -----------------------------------------------------------------------------------------------------------

P-values less than 0.05 are bold text.

Count data (presence of snoring) are presented as frequency (%).

Units for 'index' variables are events per hour.

\*Non-normally distributed continuous variables and discrete data (satisfaction, comfort and intention to use) are presented as median (IQR), and two-sided paired Wilcoxon signed-rank test is used to test for difference ('Difference (95% CI)' is the median of the pairwise differences (pseudomedian) and 95% CI for the pseudomedian).

†Normally distributed continuous variables are reported as mean (SD), and paired t-test is used to test for difference.

‡Fisher's exact test ('difference' is OR).

NREM, non-rapid eye movement; PLM, periodic leg movement; RDI, respiratory disturbance index; REM, rapid eye movement; RERA, respiratory effort-related arousal; SpO~2~, peripheral oxygen saturation.

The self-reported sleep data are presented in [table 4](#T4){ref-type="table"} with the PSG-recorded correlates and the statistical analysis of agreement. Participants recalled their sleep-onset position accurately for 34 of 40 nights (85%, κ 0.62, moderate agreement). Participants recalled their waking position accurately for 28 of 40 nights (70%, κ 0.42, weak agreement). There was a weak relationship between sleep-onset and waking position (κ 0.24). There was no agreement between the self-reported and PSG-reported number of position changes (κ 0.17). Percentage of time in each position, left, supine and right, as estimated per self-report and measured per PSG had Spearman's r of 0.76 (good correlation, p\<0.01), 0.27 (poor correlation, p=0.11), and 0.93 (excellent correlation, p\<0.01), respectively. Bland-Altman plots ([figures 4--6](#F4 F5 F6){ref-type="fig"}) demonstrated that, on average, participants' self-reports tended to overestimate the percentage of left-side and right-side sleep by 5.5% (95% CI −30.2 to 41.2) and 0.5% (95% CI −21.9 to 22.9), respectively, and underestimate the percentage of supine sleep by 7.0% (95% CI −20.1 to 34.1) when compared with the PSG-determined position.

###### 

Secondary outcomes: self-reported versus PSG-recorded sleep behaviours

                                                Self-report   PSG           Agreement
  --------------------------------------------- ------------- ------------- -------------------
  Sleep-onset position (n=40)\*                                             
   Left                                         31 (78%)      29 (73%)      Cohen's κ† 0.62
   Supine                                       2 (5%)        3 (7%)        
   Right                                        7 (17%)       8 (20%)       
  Waking position (n=40)\*                                                  
   Left                                         28 (70%)      22 (55%)      Cohen's κ† 0.42
   Supine                                       0 (0%)        5 (13%)       
   Right                                        12 (30%)      13 (32%)      
  No of position changes (n=30)‡                3 (2--4)      6 (3.3--10)   Cohen's κ§ 0.17
  \% of total sleep time in position (n=35)¶:                               
   Left                                         59.9 (28.1)   54.4 (26.4)   Spearman's ρ 0.76
   Supine                                       7.8 (20.0)    14.8 (18.7)   Spearman's ρ 0.27
   Right                                        31.3 (27.3)   30.8 (28.5)   Spearman's ρ 0.93

\*Count data are presented as: frequency (%).

†Linear/equal weighted Cohen's κ.

‡Ordinal data presented as: median (IQR).

§Unweighted Cohen's κ.

¶Continuous data presented as: mean (SD).

PSG, polysomnogram.

![Bland-Altman plot for percentage of time spent sleeping on the left side; difference between self-reported estimate and PSG-determined values. Broken lines indicate mean difference and upper and lower limits of agreement (95% CI). PSG, polysomnogram.](bmjopen-2017-020256f04){#F4}

![Bland-Altman plot for percentage of time spent sleeping supine; difference between self-reported estimate and PSG-determined values. Broken lines indicate mean difference and upper and lower limits of agreement (95% CI). Each short red line indicates an additional data point at that location (sunflower plot). PSG, polysomnogram.](bmjopen-2017-020256f05){#F5}

![Bland-Altman plot for percentage of time spent sleeping on the right side; difference between self-reported estimate and PSG-determined values. Broken lines indicate mean difference and upper and lower limits of agreement (95% CI). Each short red line indicates an additional data point at that location (sunflower plot). PSG, polysomnogram.](bmjopen-2017-020256f06){#F6}

Harms {#s3d}
-----

No participants (including the drop-outs) requested to remove the intervention or PSG equipment. There were no known harms related to the interventions or procedures in this study.

Discussion {#s4}
==========

Principal findings {#s4a}
------------------

Use of the PrenaBelt resulted in a reduction in the percentage of sleep time supine in comparison with the sham, and we were unable to demonstrate an effect on maternal sleep architecture or respiration.

Strengths and weaknesses in relation to other studies {#s4b}
-----------------------------------------------------

Our study only included two nights for each participant and was a randomised pilot trial; therefore, caution should be taken when extrapolating our results across the third trimester with regard to efficacy and compliance---PT in non-pregnant individuals with positional OSA has sustained efficacy in the long term but decreasing compliance from 93% at 1 month,[@R40] 74% at 3 months[@R41] and 60% at 6 months.[@R42]

In recent studies of PT in non-pregnant individuals with positional OSA, PT devices incorporating active supine sensing technology and vibration mechanisms have been shown to be more effective in reducing supine sleep than inactive pressure-point PT devices like the PrenaBelt.[@R41] In comparison to a study of pressure-point PT in non-pregnant individuals with positional OSA by Heinzer *et al*,[@R41] the PrenaBelt resulted in a lesser reduction in mean percentage of sleep time supine; however, in contrast, we did not have a non-intervention night as Heinzer *et al* did. The sham, by intrinsic characteristics, may have caused a reduction in supine sleep in comparison to a non-intervention night. O'Brien and Warland[@R6] reported a non-interventional, one-night, in-home study of 51 healthy women in their second and third trimester using ambulatory PSG; in a subgroup of participants in their third trimester (n=33), the median percentage of overall sleep time spent supine was 26.5%. McIntyre *et al*,[@R7] in a similar non-interventional, one-night, in-home, ambulatory PSG study in 30 healthy women in the third trimester, reported the median percentage of overall sleep time spent supine to be 19%. Participants were not asked to adopt or try to maintain any sleep position in either study. Both of these studies reported a greater median percentage of overall sleep time spent supine than that in the current study (16.4%), which indicates that the sham device may have affected position. This, along with differences inherent to pregnancy (eg, body habitus, increased sleep disruption) may account for the lesser reduction in mean percentage of sleep time supine achieved by the PrenaBelt in comparison Heinzer *et al*.[@R41]

Zaremba *et al* undertook a randomised, cross-over, PSG study in 30 postpartum women sleeping in non-elevated and 45° elevated body position and reported moderate to severe OSA in 20% of the participants.[@R44] The minimum SpO~2~ was higher (p 0.03) and AHI was reduced (p 0.03) in the 45° elevated body position in comparison to non-elevated without affecting sleep quantity or quality. In our analysis, we were unable to demonstrate any differences in sleep architecture or duration despite a significant difference in body position (less supine time).

Seventy-three per cent of participants in the study by McIntyre *et al* [@R7] recalled their sleep-onset position accurately (κ 0.52), which is a lower accuracy than our results (85% accurate, κ 0.62) possibly because each of our participants underwent two PSG nights and, after being asked to recall various details about their sleep after their first PSG night, may have anticipated these questions again after their second PSG night. Forty per cent of McIntyre *et al*'s participants recalled their waking position accurately (κ 0.24), which is a lower accuracy than our results (70% accurate, κ 0.42). Being an ambulatory PSG, McIntyre *et al*'s study did not include EEG---they estimated sleep and wake times by predefined video criteria (ie, lack of movement) and not by brain activity and noted that this may have introduced discrepancy between their participants' self-reports and the video assessment criteria, thus reducing their calculated accuracy. We reported a weak relationship (κ 0.24) between sleep-onset and waking position via PSG-determination, whereas previous studies have reported discrepant results---McIntyre *et al* reported no relationship (κ −0.13) via video determination, and the Auckland Stillbirth Study reported a strong relationship (Pearson's r 0.72) via self-reports[@R2]; however, our study has shown self-reports of sleep-onset and waking position to have only moderate and weak agreement with the gold standard (PSG), respectively, which points to reliance on non-PSG methods (eg, self-reports) as a potential source of this discrepancy.

Warland and Dorrian reported a three-night observational study of 30 healthy women in late pregnancy and found moderate basic correlation between self-reported and video-determined time on the left (r=0.418)[@R8]; however, they did not report correlations for right or supine sleep. We report a good correlation between self-reported and PSG-determined time on the left (Spearman's r 0.76, p\<0.01). Notably, we found poor correlation between self-reports and PSG-determined supine time and that pregnant women tend to underestimate this value. There are only two other studies investigating reliability of adults' self-reports of sleep position[@R45]; both consist of non-pregnant adults, have conflicting results with each other, and are not reported in adequate detail for comparison to our results.

In the non-pregnant population, approximately 20% of a typical night's sleep is spent in the REM state and 80% is spent in the NREM state. The sleep architecture in the current study is consistent with previously reported patterns during pregnancy, that is, reduced slow-wave sleep, REM sleep and sleep efficiency.[@R47]

Meaning of the study {#s4c}
--------------------

The previous studies by Owusu *et al* [@R1] and O'Brien and Warland[@R6] recommended the development and testing of a PT device for pregnant women. In our study, a PT intervention was implemented in a population of healthy, third-trimester, pregnant women during sleep in a clinical sleep laboratory environment over two nights. This study extends the work of Stacey *et al*,[@R2] Gordon *et al*,[@R3] McCowan *et al*,[@R4] and Warland and Mitchell[@R52] by finding that supine sleep position in late pregnancy can be reduced with PT.

Left-side sleeping is common among pregnant women. This may be a more comfortable position but also may be related to the 'sleep-on-side' messages prevalent on the internet and among maternity care providers. Women in our study preferentially settled to sleep on their left for 73% of the nights and right for 20% of the nights. This is corroborated by McCowan *et al* [@R4] who reported a significant increase in left-sided going-to-sleep position (43% to 58%) and small decrease in supine going-to-sleep position (5% to 3.8%) in New Zealand over an approximate 5-year period following publicity of The Auckland Stillbirth Study by Stacey *et al*.[@R2] If the supine sleeper is to be identified by history taking and stratified for targeted education or intervention, obstetricians, midwives and nurses should be aware that despite sleep-on-side knowledge and high rates of lateral going-to-sleep position, most pregnant women continue to spend a significant amount of time supine during sleep in late pregnancy per our study and previous studies.[@R6] Also, per our study, pregnant women's estimates of time in each sleep position, while relatively accurate for lateral sleeping positions, underestimate the time they spend supine. Together, this suggests that healthcare providers may need to recommend interventions to prevent unintentional supine positioning during sleep.

Strengths {#s4d}
---------

Strengths of this study include its rigorous methodology and use of the gold-standard sleep diagnostic test in a controlled laboratory setting. The sham intervention ensured that on the sham PSG night, participants received any specific benefit of any element of the PrenaBelt above and beyond all benefits that might be attributed to its ability to cause pressure points and, thus, reduced treatment bias. The crossover allowed each participant to serve as her own control for comparison of intervention effect on outcomes. Allocation concealment and randomisation of participants to intervention order helped avoid allocation bias and the potential impact of changes to sleep across the two PSG nights that could have resulted from familiarisation with the equipment and environment. Blinding of the participants, RAs, Registered PSG Technicians and the sleep specialist physician further reduced potential sources of bias and strengthened data integrity.

Weaknesses {#s4e}
----------

Weaknesses of this study included that we had no baseline sleep data (run-in measurement) to which we could compare the PrenaBelt and sham nights; therefore, conclusions cannot be made regarding the effect, if any, of the PrenaBelt on sleep architecture and respiration in relation to no intervention. Participants' unfamiliarity with the sleep environment also may have affected sleep quantity and quality; however, we were unaware of any impact reported by participants. Period effects and carryover may have occurred due to advancing gestation and familiarisation with the sleep environment/equipment; however, given the median washout period (1 day) was negligible in the context of a 12-week third trimester, period effects from the washout were, at most, minimal. On the second PSG night, participants were exposed to the alternate intervention and could have unblinded themselves if they remembered what the intervention felt like on the first PSG night; however, we are unaware of what effect this may have had. The current study was conducted in a cohort of healthy, non-obese and majority Caucasian pregnant women. Due to the small sample size, this study may be underpowered and potentially overstate the true reduction in percentage of supine sleep; however, the sleep time in our study was relatively short (median 5.87 hours). Our participants reported a median of 8 hours overnight sleep duration at home; therefore, even if the reduction in supine sleep is lower than we observed, over a longer sleep duration, the PrenaBelt is still likely to result in a significant amount of supine sleep avoided. The power analysis was performed using the one-sided t-test, which could be a source of systemic confounding. Because of the fragility of our primary outcome (p 0.03), a confounding could shift our conclusions into statistical non-significance. This stresses the importance of future research to ascertain if our observed effects persist.

Future research {#s4f}
---------------

To date, it is unclear whether formal advice, given by a maternity care provider to a pregnant woman, about sleeping position in late pregnancy is less, as, or more effective in reducing supine sleep in comparison to a PT device such as the PrenaBelt. Future research comparing advice versus a PT intervention in the home setting is imperative. If sleeping supine is potentially harmful to the fetus, the amount of supine time that is harmful needs quantification in order to target interventions to avoid this. Given that estimations of time in each body position during sleep are based on the recollection of an unconscious state and thus inherently inaccurate, future research should not rely on self-reports but should incorporate an objective measure of body position during sleep throughout the third trimester allowing body position to be directly linked to pregnancy outcomes. The results of our randomised pilot trial warrant future, large, multiethnic studies that include women with a range of pregnancy and health conditions to ascertain if the observed effects persist.

Other information {#s5}
=================

Protocol {#s5a}
--------

Full details of the trial protocol are available with the full text of this article (see online [supplementary file 1](#SP1){ref-type="supplementary-material"}).

10.1136/bmjopen-2017-020256.supp1

Supplementary Material
======================

###### Reviewer comments

###### Author\'s manuscript

The authors would like to thank the 20 pregnant volunteers who gave up their time and the comfort of home to spend two nights in our study. Darlene Baxendale, Antonia Hall, Nooshin Sobhani and Laura Miller for their support as research assistants, Janet Slaunwhite for her administrative support and RPSGTs Antonya Schulz, Carrie Edwards-Young, Tracey Kent and Kelmarie Cole for their technical expertise in polysomnography setup and scoring. There were no patient advisers.

**Twitter:** \@allankember

**Contributors:** AJK designed the protocol, secured funding, ethics approval and the research contract, trained the study personnel, maintained the study master record, facilitated PSG studies as an unblinded personnel, monitored data collection, cleaned and analysed the data, and drafted and revised the paper. He is the guarantor. AJK and AB conceptualised the PrenaBelt. KC designed and manufactured the PrenaBelt research samples. DLM, HMS, LMO, AB, JC, MBB, KC and AI designed the protocol. HMS oversaw participant recruitment and was the principal investigator responsible for all aspects of the trial. DLM was the supervising investigator, oversaw the PSG studies at the trial site and interpreted the PSG studies. MBB wrote the statistical plan and oversaw the statistical analysis. JHW maintained the study master record, facilitated PSG studies as an unblinded personnel, monitored data collection, and cleaned and analysed the data. AI negotiated the research contract and managed the trial funds. DLM, HMS, LMO, AB, JC, JHW, MBB, KC and AI made intellectual contributions to the paper.

**Funding:** This trial was supported by funding from Grand Challenges Canada Stars in Global Health Award, Round 7, Number 0629-01-10 and the IWK Health Centre Dr. H.B. Atlee Endowment Award. Grand Challenges Canada is funded by the Government of Canada.

**Competing interests:** AJK and AB are officers at GIRHL, which has a patent application for the PrenaBelt (\#WO2016176632A1) on which AJK, AB and KC are listed as inventors. DLM reports grants from Bresotec and grants from CIHR/Industry Grant (Phillips) outside the submitted work. HMS, JC, JHW, MBB, AI and LMO have declared no support from any organisation for the submitted work, no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, and no other relationships or activities that could appear to have influenced the submitted work.

**Patient consent:** Not required.

**Ethics approval:** This trial was approved by the IWK Health Centre Research Ethics Board in June 2015 (Project No. 1018753).

**Provenance and peer review:** Not commissioned; externally peer reviewed.

**Data sharing statement:** Extra data can be accessed via the Dryad data repository at [http://www.datadryad.org/](link%20text)with the doi:10.5061/dryad.qg1b2n0.
